MAY 19 2004 K 040433
510(k) Summary of Safety and Effectiveness for the
WaveLight Laser Technologie, AG SINON laser system.
This 510(k) Summary of Safety and Effectiveness is being submitted in accordance with
the requirements of the SMDA 1990 and 21 CFR 807.92.
1. General Information
Submitter: WaveLight Laser Technologie, AG
Am Wolfsmantel 5
. 91058 Erlangen
Germany
Contact Person: Maureen O’Connell
5 Timber Lane .
North Reading, MA 01864
Telephone: 978-207-1245
Fax: 978-207-1246
Summary Preparation Date: February 10, 2004
2. Names
Device Name: SINON
Classification Name: Laser Instrument, Surgical Powered
Product Code: GEX
Panel: Dermatology and Plastic Surgery
3. Predicate Devices
The SINON laser system is substantially equivalent to the Aesculap-Meditec
RubyStar Laser System with Normal and Q-Switch Mode (K991285), the
Spectrum Medical Technologies RD-1200 (K910422), the MLT Laser
Technologies Inc. MLT R694 (K9909002) and the Mehl/Biophile Inc. Chromos
694 (K971814).
4. Device Description
The SINON is a 694 nm Ruby laser system which can be operated in two
different modes. The quality-switch or Q-switch or QS Operating Mode is
characterized by extremely short pulse widths (ns = 10°s) and high peak power
(MW = 10° W). The QS Operating Mode in the SINON is used for the removal of
tattoos and treatment of pigmented lesions. The second mode is the Free-Running
Operating Mode which is used for the removal of hair.
6050193

5. Indications for Use .
The SINON is indicated:
1. In the Q-Switch Mode, for the cutting, vaporization, or ablation of soft tissue.
This includes the removal of tattoos and treatment of benign pigmented lesions.
2. Inthe Free-Running Mode, for the removal of unwanted hair in patients with
Fitzpatrick skin types of I and II.
6. Performance Data
None presented.
f
608020

stray,
f Z DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
AE
"en Food and Drug Administration
9200 Corporate Boulevard
WAY 19 2004 Rockville MD 20850
WaveLight Laser Technologic, AG
c/o Ms. Maureen O’Connell ;
5 Timber Lane ;
North Reading, Massachusetts 01864
Re: K040433
Trade/Device Name: SINON
Regulation Number: 21 CFR 878.4810
Regulation Name: Laser surgical instrument for use in general and
‘ plastic surgery and in dermatology
Regulatory Class: II :
Product Code: GEX
Dated: February 13, 2004
Received: February 19, 2004
Dear Ms. O’ Connell:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class II (Special Controls) or class HI (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies, -You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
: forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 - Ms. Maureen O’Connell
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (301) 594-4659. Also, please note the regulation entitled,
"Misbranding by reference to premarket notification” (21CFR Part 807.97). You may obtain
other general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
: (301) 443-6597 or at its Internet address http://www. fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Aol Wilbon —
free M. Witten, Ph.D., M.D.
Director
Division of General, Restorative
and Neurological Devices

Office of Device Evaluation

Center for Devices and Radiological Health
Enclosure :

Indications for Use’
510(k) Number (if known): K040433 :
Device Name: SINON
Indications For Use: 1. In the Q-Switch Mode, for the cutting, vaporization, or ablation of soft tissue.
This includes the removal of tattoos and treatment of benign pigmented lesions.
2. In the Free-Running Mode, for the removal of unwanted hair in patients with
Fitzpatrick skin types of | and II.
Prescription Use xX AND/OR Over-The-Counter Use
(Part 21 CFR 801 Subpart D) (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF
NEEDED)
Concurrence of CDRH, Office of Device Eyaluation (ODE)
afl 2y| cS
oa .
f isitSenony |
Division of General, Restorative,
and Neurological Devices
Page 1 of _1_
wine y oracatiam  KOGOF 33

